
Join to View Full Profile
24 Miles Center WayDamariscotta, ME 04543
Phone+1 207-563-4046
Fax+1 207-810-4994
Dr. Connelly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1993 - 1996
- Cleveland Clinic Foundation/Akron GeneralResidency, Internal Medicine, 1980 - 1982
- Akron General Medical Center/NEOMEDInternship, Transitional Year, 1979 - 1980
- Texas College of Osteopathic MedicineClass of 1979
Certifications & Licensure
- NH State License 2025 - 2027
- HI State License 2024 - 2026
- ME State License 2007 - 2026
- MT State License 2022 - 2026
- ND State License 2022 - 2025
- WY State License 2022 - 2023
- OH State License 1982 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Publications & Presentations
PubMed
- 8 citationsCommunity-based phase II trial of pentostatin, cyclophosphamide, and rituximab (PCR) biochemotherapy in chronic lymphocytic leukemia and small lymphocytic lymphoma.Robert O. Dillman, Marshall T. Schreeder, Jeremy K. Hon, Elizabeth F. Connelly, Carol DePriest
Cancer Biotherapy & Radiopharmaceuticals. 2007-06-28
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: